Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för atuveciclib. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

12 träffar

Bibliografisk träff 2024-04-02

Recent Discovery and Development of Inhibitors that Target CDK9 and Their Therapeutic Indications.

Zhang Y, Shan L, Tang W, Ge Y, Li C, Zhang J.

J Med Chem · research support, non-u.s. gov't; review; journal article · DOI 10.1021/acs.jmedchem.4c00312

Bibliografisk träff 2023-10-23

Discovery of Selective and Potent Macrocyclic CDK9 Inhibitors for the Treatment of Osimertinib-Resistant Non-Small-Cell Lung Cancer.

Wu T, Yu B, Xu Y, Du Z, Zhang Z, Wang Y, Chen H, Zhang LA, Chen R, Ma F, Gong W, Yu S, Qiu Z, Wu H, Xu X, Wang J, Li Z, Bian J.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jmedchem.3c01400

Bibliografisk träff 2023-10-06

Design, synthesis, and biological evaluation of novel 4,4'-bipyridine derivatives acting as CDK9-Cyclin T1 protein-protein interaction inhibitors against triple-negative breast cancer.

Gao G, Li J, Cao Y, Li X, Qian Y, Wang X, Li M, Qiu Y, Wu T, Wang L, Fang M.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2023.115858

Bibliografisk träff 2022-10-27

Design, synthesis and anticancer evaluation of selective 2,4-disubstituted pyrimidine CDK9 inhibitors.

Xu Z, Zhang B, Liu Z, Gou S.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2022.114875

Bibliografisk träff 2022-04-29

From Structure Modification to Drug Launch: A Systematic Review of the Ongoing Development of Cyclin-Dependent Kinase Inhibitors for Multiple Cancer Therapy.

Shi Z, Tian L, Qiang T, Li J, Xing Y, Ren X, Liu C, Liang C.

J Med Chem · research support, non-u.s. gov't; systematic review; journal article · DOI 10.1021/acs.jmedchem.1c02064

Bibliografisk träff 2020-12-10

Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion.

Qiu X, Li Y, Yu B, Ren J, Huang H, Wang M, Ding H, Li Z, Wang J, Bian J.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2020.113091

Bibliografisk träff 2020-09-23

Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry.

Mäder P, Kattner L.

J Med Chem · journal article · DOI 10.1021/acs.jmedchem.0c00960

Bibliografisk träff 2020-09-17

Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update.

Wu T, Qin Z, Tian Y, Wang J, Xu C, Li Z, Bian J.

J Med Chem · research support, non-u.s. gov't; review; journal article · DOI 10.1021/acs.jmedchem.0c00744

Bibliografisk träff 2020-08-26

Rational Design and Evaluation of 6-(Pyrimidin-2-ylamino)-3,4-dihydroquinoxalin-2(1<i>H</i>)-ones as Polypharmacological Inhibitors of BET and Kinases.

Lv K, Chen W, Chen D, Mou J, Zhang H, Fan T, Li Y, Cao D, Wang X, Chen L, Shen J, Pei D, Xiong B.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jmedchem.0c00962

Bibliografisk träff 2019-08-26

Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015-2019).

Sánchez-Martínez C, Lallena MJ, Sanfeliciano SG, de Dios A.

Bioorg Med Chem Lett · research support, non-u.s. gov't; review; journal article · DOI 10.1016/j.bmcl.2019.126637

Bibliografisk träff 2019-06-15

Design of wogonin-inspired selective cyclin-dependent kinase 9 (CDK9) inhibitors with potent in vitro and in vivo antitumor activity.

Wang J, Li T, Zhao T, Wu T, Liu C, Ding H, Li Z, Bian J.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2019.06.024

Bibliografisk träff 2017-09-04

Structural insights of cyclin dependent kinases: Implications in design of selective inhibitors.

Kalra S, Joshi G, Munshi A, Kumar R.

Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2017.08.071